Skip to content

Merit Medical Systems MMSI Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin48.7%+1.3pp47.4%+1.0pp46.4%+1.3pp45.1%-0.1pp
Operating margin12.2%+0.7pp11.5%+1.6pp9.9%+2.2pp7.6%+1.9pp
Net margin8.5%-0.4pp8.9%+1.4pp7.5%+1.0pp6.5%+2.0pp
EBITDA margin20.3%+1.3pp19%+2.0pp17%+2.3pp14.7%+1.2pp
Free cash flow margin14.2%+0.5pp13.7%+4.9pp8.8%+2.8pp6%-5.1pp
Returns
Return on equity8.7%-0.7pp9.3%+1.3pp8%+1.2pp6.8%+2.0pp
Return on assets5%0.0pp5.1%+0.3pp4.7%+0.2pp4.5%+1.6pp
Return on invested capital7.4%-0.2pp7.6%+0.3pp7.3%+0.7pp6.6%+2.5pp
Efficiency
Asset turnover0.6×0.0×0.6×-0.1×0.6×-0.1×0.7×0.0×
Inventory turnover2.4×+0.1×2.3×0.0×2.4×-0.2×2.6×-0.2×
Liquidity
Current ratio4.3×+0.1×4.3×-1.2×5.4×+3.0×2.4×+0.4×
Quick ratio2.9×+0.1×2.9×-1.1×+2.8×1.2×+0.1×
Cash ratio1.9×+0.1×1.7×-1.1×2.9×+2.6×0.3×0.0×
Leverage
Debt-to-equity0.5×-0.1×0.6×-0.2×0.7×+0.5×0.2×-0.1×
Debt-to-assets0.3×0.0×0.3×-0.1×0.4×+0.2×0.2×0.0×
Net debt / EBITDA1.2×-0.4×1.6×+0.2×1.4×+0.2×1.2×-0.5×
Interest coverage+2.0×-3.0×-5.8×13.8×+2.2×
Per Share
Book value per share$26.20+12.8%$23.24+12.8%$20.60+3.8%$19.84+9.5%
Valuation
Market capitalization$5.23B-7.3%$5.64B+28.4%$4.39B+9.2%$4.02B+14.3%
Enterprise value$5.6B-7.5%$6.05B+29.0%$4.69B+11.0%$4.23B+12.4%
Price / earnings40.7×-6.2×46.8×+0.3×46.5×-7.4×53.9×-18.6×
Price / sales3.4×-0.7×4.2×+0.7×3.5×0.0×3.5×+0.2×
Price / book3.3×-0.8×4.1×+0.4×3.7×+0.1×3.5×+0.1×
EV / EBITDA18.2×-5.2×23.4×+1.5×21.9×-3.0×25×-1.0×
EV / sales3.7×-0.8×4.5×+0.7×3.7×+0.1×3.7×+0.2×
Free cash flow yield4.1%+0.8pp3.3%+0.8pp2.5%+0.8pp1.7%-1.7pp
Earnings yield2.5%+0.3pp2.1%0.0pp2.2%+0.3pp1.9%+0.5pp
PEG ratio+4.3×1.7×0.0×1.7×+0.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Merit Medical Systems's profit margins?
Merit Medical Systems (MMSI) runs a 48.7% gross margin and a 12.2% operating margin, with a 9.0% net margin.
Where do Merit Medical Systems's ratios come from?
Every ratio is computed from Merit Medical Systems's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.